Fulcrum Capital’s Idexx Laboratories IDXX Stock Holding History

Fulcrum Capital’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-615	Closed	-$254K	–	113
2024 Q4	$254K	Hold	615	–	–	0.05%	103
2024 Q3	$311K	Sell	615 -160	-21%	-$77.7K	0.07%	91
2024 Q2	$378K	Hold	775	–	–	0.09%	76
2024 Q1	$418K	Hold	775	–	–	0.1%	74
2023 Q4	$430K	Hold	775	–	–	0.11%	74
2023 Q3	$339K	Hold	775	–	–	0.1%	78
2023 Q2	$389K	Hold	775	–	–	0.1%	78
2023 Q1	$388K	Buy	+775	New	+$371K	0.1%	76

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Fulcrum Capital's IDXX Position: Q1 2025 in Review

Fulcrum Capital sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 615 shares — an estimated $254K sold.

Fulcrum Capital first reported a position in IDXX in Q1 2023 and held it in 8 quarters. The position peaked at $430K in Q4 2023. 1,144 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

Fulcrum Capital reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
Fulcrum Capital sold 615 Idexx Laboratories shares in Q1 2025, an estimated $254K.
Fulcrum Capital first reported a position in Idexx Laboratories in Q1 2023 and held it in 8 quarters.
Fulcrum Capital's Idexx Laboratories position peaked at $430K in Q4 2023.
1,144 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Fulcrum Capital's 13F filing for Q1 2025, filed 8 Apr 2025.